SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-034445
Filing Date
2022-02-10
Accepted
2022-02-10 16:13:03
Documents
4
Group Members
LILLY VENTURES FUND I LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d258548dsc13ga.htm SC 13G/A 56326
2 EX-99.1 d258548dex991.htm EX-99.1 6225
3 EX-99.2 d258548dex992.htm EX-99.2 4977
4 EX-99.3 d258548dex993.htm EX-99.3 4778
  Complete submission text file 0001193125-22-034445.txt   74047
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 22614045
SIC: 2834 Pharmaceutical Preparations